bioAffinity Announces Publication Of Clinical Review And White Paper For Incorporating CyPath Lung Into Pulmonary Nodule Evaluation And Cancer Surveillance
Titled "Lung Nodules, Lung Microenvironment, Predictive Models and Clinician Risk Stratification Using CyPath® Lung Testing for Early Diagnosis of Lung Cancer," the paper examines the growing clinical challenge
A company published a detailed research paper showing how their lung-cancer test works and helps doctors decide which patients need more care. This kind of scientific proof can help doctors trust and use the tool more, which matters for the company's growth.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.